Breaking News

Ofichem Acquires Swedish Site from Meribel Pharma Solutions

Enhances Ofichem’s innovation offering and expands its biotech footprint across Nordic countries.

Author Image

By: Charlie Sternberg

Associate Editor

Meribel Pharma Solutions’ site in Uppsala, Sweden.

Ofichem, a European CDMO specializing in high-quality active pharmaceutical ingredients (APIs) and integrated drug development and manufacturing services, has acquired Meribel Pharma Solutions’ site in Uppsala, Sweden, enhancing its ability to support early-phase, IP-driven drug substance development and expanding its non-GMP capabilities in the small-molecule space. The Uppsala site, formerly part of Recipharm, is home to 20 employees and specializes in small-scale, early-phase development w...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters